Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...
The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled ...